KLEBSIELLA-ENTEROBACTER-SERRATIA
GROUP
|
Properties |
Pathogenesis |
Clinical
findings |
Laboratory
diagnosis |
Treatment
& Prevention |
|
Species most often involved in human infections. K.pneumoniae has a very large capsule which gives its colonies a striking mucoid appearance. S.marcescens produces red-pigmented colonies. |
Predisposing conditions to K.pneumoniae infections: - advanced age - chronic respiratory disease - diabetes - alcoholism K.pneumoniae is carried in the respiratory tracts of about 10% of normal people, who are prone to pneumonia if host defenses are lowered. Enterobacter and Serratia infections are related to hospitalization, especially to invasive procedures such as intravenous catheterization, respiratory intubation, & urinary tract manipulations. |
Diseases: - urinary tract infections - pneumonia - bacteremia & secondary spread to other areas such as the meninges. Pneumonia caused by Klebsiella produces a thick, bloody sputum & can progress to necrosis & abscess formation. |
Organisms of this group produce lactose-fermenting (colored) colonies on differential agar such as MacConkey’s or EMB. Serratia, a late lactose fermenter, can give a negative reaction. These organisms are separated by the use of biochemical tests. |
An aminoglycoside, e.g. gentamicine & a cephalosporin, e.g. cefotaxime, are used empirically until the results of the testing are known. Prevention: - changing the site of intravenous catheters. - removing urinary catheters when they are no longer needed. - taking proper care of respiratory therapy devices. No vaccine. |